Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2013. Start Trial.
Date Value
September 30, 2026 94.35%
August 31, 2026 94.35%
July 31, 2026 94.35%
June 30, 2026 94.35%
May 31, 2026 94.35%
April 30, 2026 94.35%
March 31, 2026 94.35%
February 28, 2026 94.35%
January 31, 2026 94.35%
December 31, 2025 94.35%
November 30, 2025 94.35%
October 31, 2025 94.35%
September 30, 2025 94.35%
August 31, 2025 94.35%
July 31, 2025 94.35%
June 30, 2025 94.35%
May 31, 2025 94.35%
April 30, 2025 94.35%
March 31, 2025 94.35%
February 28, 2025 94.35%
January 31, 2025 94.35%
December 31, 2024 94.35%
November 30, 2024 93.39%
October 31, 2024 91.80%
September 30, 2024 91.53%
Date Value
August 31, 2024 89.94%
July 31, 2024 89.94%
June 30, 2024 89.94%
May 31, 2024 89.94%
April 30, 2024 89.94%
March 31, 2024 89.94%
February 29, 2024 89.81%
January 31, 2024 87.99%
December 31, 2023 85.92%
November 30, 2023 85.92%
October 31, 2023 85.92%
September 30, 2023 85.92%
August 31, 2023 85.92%
July 31, 2023 85.92%
June 30, 2023 85.92%
May 31, 2023 85.92%
April 30, 2023 85.59%
March 31, 2023 85.47%
February 28, 2023 85.47%
January 31, 2023 85.47%
December 31, 2022 85.47%
November 30, 2022 85.47%
October 31, 2022 85.47%
September 30, 2022 85.47%
August 31, 2022 76.43%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Nicox SA 96.28%
DBV Technologies SA 98.19%
Cellectis SA 97.08%
Genfit SA 90.85%
Innate Pharma SA 85.56%